Reporting quality and risk of bias analysis of published RCTs assessing anti-CGRP monoclonal antibodies in Migraine Prophylaxis: a systematic review. | 2024 | Journal of Clinical Medicine |
The transition of medication overuse status by acute medication categories in episodic or chronic migraine patients to non-overuse status after receiving anti-CGRP monoclonal antibodies: a systematic review and meta-analysis of phase 3 randomized control trial. | 2024 | Neurological Sciences |
Clinical effectiveness of pharmacological interventions for managing chronic migraine in adults: a systematic review and network meta-analysis. | 2023 | The Journal of Headache and Pain |
Effectiveness of calcitonin gene-related peptide monoclonal antibodies in the prevention of migraine: a systematic review and meta-analysis of observational cohort studies. | 2023 | Clinical Drug Investigation |
Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: a systematic review and network meta-analysis. | 2023 | Cephalalgia |
Effectiveness and safety of chronic migraine preventive treatments: a systematic literature review. | 2023 | Pain and Therapy |
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: a systematic review and network meta-analysis of phase 3 randomised controlled trials. | 2023 | Cephalalgia |
Gender bias in clinical trials of biological agents for migraine: a systematic review. | 2023 | PLoS One |
Comparative efficacy and safety of five anti-calcitonin gene-related peptide agents for migraine prevention: a network meta-analysis. | 2023 | Clinical Journal of Pain |
Methodological considerations on real-world evidence studies of monoclonal antibodies against the CGRP-pathway for migraine: a systematic review. | 2023 | The Journal of Headache and Pain |
Comparative effectiveness and tolerability of the pharmacology of monoclonal antibodies targeting the calcitonin gene-related peptide and its receptor for the prevention of chronic migraine: a network meta analysis of randomized controlled trials. | 2022 | Neurotherapeutics |
Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review. | 2022 | European Journal of Medical Research |
A systematic review of economic evaluations of pharmacological treatments for adults with chronic migraine. | 2022 | The Journal of Headache and Pain |
Monoclonal antibodies against calcitonin gene-related peptide for migraine prophylaxis: a systematic review of real-world data. | 2022 | Cells |
Monthly versus quarterly fremanezumab for the prevention of migraine: a systemic review and meta-analysis from randomized controlled trials. | 2021 | Naunyn-Schmiedeberg's Archives of Pharmacology |
Efficacy of calcitonin gene-related peptide (CGRP) receptor blockers in reducing the number of monthly migraine headache days (MHDs): a network meta-analysis of randomized controlled trials. | 2021 | Journal of the Neurological Sciences |
Calcitonin gene-related peptide monoclonal antibodies versus botulinum neurotoxin A in the preventive treatment of chronic migraine: an adjusted indirect treatment comparison meta-analysis. | 2021 | Frontiers in Pharmacology |
Efficacy and safety of monoclonal antibody against calcitonin gene-related peptide or its receptor for migraine: a systematic review and network meta-analysis. | 2021 | Frontiers in Pharmacology |
Anti-CGRP monoclonal antibodies for migraine prevention: a systematic review and likelihood to help or harm analysis. | 2021 | Cephalalgia |
Calcitonin gene–related peptide monoclonal antibody versus botulinum toxin for the preventive treatment of chronic migraine: evidence from indirect treatment comparison. | 2021 | Frontiers in Pharmacology |
Indirect comparison of topiramate and monoclonal antibodies against CGRP or its receptor for the prophylaxis of episodic migraine: a systematic review with meta-analysis. | 2021 | CNS Drugs |
Efficacy and safety of anti-calcitonin gene-related peptide monoclonal antibodies for treatment of chronic migraine: a systematic review and network meta-analysis. | 2021 | Clinical Neurology and Neurosurgery |
Quality of life related to functional disability in migraine patients: a systematic review and network meta-analysis. | 2021 | The Clinical Journal of Pain |
Safety and efficacy of fremanezumab for the prevention of migraine: a meta-analysis from randomized controlled trials. | 2020 | Frontiers in Neurology |
Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine - an updated systematic review and meta-analysis. | 2020 | BMC Neurology |
Optimal treatment strategy of fremanezumab in migraine prevention: a systematic review with network meta‑analysis of randomized clinical trials. | 2020 | Scientific Reports |
Monoclonal antibodies against calcitonin gene-related peptide in chronic migraine: an adjusted indirect treatment comparison. | 2020 | Farmacia Hospitalaria |
CGRP, a target for preventive therapy in migraine and cluster headache: systematic review of clinical data. | 2019 | Cephalalgia |